Researchers develop a murine model of TEK Schlemm's canal conditional knockdown glaucoma May 10, 2022 No Comments
Targeting NR2E3 is a potential approach to avoid photoreceptor degeneration in retinitis pigmentosa May 9, 2022 No Comments
PharmAbcine reports GLP toxicology results for TIE2-activating antibody PMC-403 April 27, 2022 No Comments
ViGeneron and Daiichi Sankyo enter follow-on collaboration for gene therapy for eye diseases April 26, 2022 No Comments
AAV gene therapy shows safety and efficacy to target ON-bipolar cells in the LRIT3-CSNB canine model April 14, 2022 No Comments